| scholarly article | Q13442814 |
| P50 | author | Daniel A. Lawrence | Q39600113 |
| P2093 | author name string | Alexander W Lohman | |
| Yan Ji | |||
| William P Fay | |||
| Elizabeth A Grunz | |||
| Meredith J Stevenson | |||
| Tammy L Strawn | |||
| P2860 | cites work | Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice | Q24310475 |
| The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin | Q24310652 | ||
| Role of vitronectin and its receptors in haemostasis and vascular remodeling | Q28272554 | ||
| Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1 | Q28345650 | ||
| Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor | Q30449306 | ||
| Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects | Q30700072 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury | Q35840308 | ||
| Vascular functions of the plasminogen activation system | Q36767411 | ||
| The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. | Q37423754 | ||
| The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. | Q40582221 | ||
| Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries | Q40724602 | ||
| PAI-1, fibrosis, and the elusive provisional fibrin matrix | Q40736087 | ||
| Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
| Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices | Q42425209 | ||
| Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. | Q43909364 | ||
| Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways | Q44728938 | ||
| Murine model of neointimal formation and stenosis in vein grafts | Q47710842 | ||
| Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice. | Q51816751 | ||
| Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin | Q52394914 | ||
| Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. | Q52541726 | ||
| Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. | Q53622123 | ||
| Identification of the collagen-binding domain of vitronectin using monoclonal antibodies | Q69039095 | ||
| Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis | Q71675475 | ||
| Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1 | Q73536945 | ||
| Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure | Q73762705 | ||
| The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery | Q73892948 | ||
| Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque | Q74251022 | ||
| Antibody to thrombin receptor inhibits neointimal smooth muscle cell accumulation without causing inhibition of platelet aggregation or altering hemostatic parameters after angioplasty in rat | Q74582134 | ||
| Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis | Q77381388 | ||
| Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions | Q78327780 | ||
| Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model | Q78664253 | ||
| Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2 | Q81472578 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 1781-1787 | |
| P577 | publication date | 2011-05-12 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts | |
| P478 | volume | 31 |
| Q39154689 | Altered phenotypic gene expression of 10T1/2 mesenchymal cells in nonuniformly stretched PEGDA hydrogels |
| Q42941011 | C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts |
| Q53650930 | Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia. |
| Q50127096 | Inflammation in Vein Graft Disease. |
| Q52659385 | Long noncoding RNA RP4 functions as a competing endogenous RNA through miR-7-5p sponge activity in colorectal cancer. |
| Q49425306 | Oxidized low density lipoprotein facilitates tumor necrosis factor‑α mediated chondrocyte death via autophagy pathway |
| Q42738253 | Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation |
| Q47657969 | Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin |
| Q35351530 | Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs |
| Q37007335 | Platelets: Context-Dependent Vascular Protectors or Mediators of Disease |
| Q47994855 | Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization |
| Q47357014 | Role of IL-17 in LPS-induced acute lung injury: an in vivo study |
| Q57059706 | S100B regulates inflammatory response during osteoarthritis via fibroblast growth factor receptor 1 signaling |
| Q90291338 | TRAF6 mediates high glucose-induced endothelial dysfunction |
| Q41663331 | The ADP antagonist MRS2179 regulates the phenotype of smooth muscle cells to limit intimal hyperplasia |
| Q92837650 | Upregulation of MiR-29b contributes to mesenchymal stem cell dysfunction in patients with severe pre-eclampsia |
| Q38837879 | Vein graft failure: from pathophysiology to clinical outcomes. |
Search more.